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Synthesis of some novel metal complex of different transition metal likes Co, Cu and Ni have been carried out with 
(E)-5-(3-(3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)acryloyl)-2-hydroxybenzamide ligand with the appropriate metal 
salts i.e. Co(CH3COO)2·6H2O, Ni(CH3COO)2·6H2O and Cu(CH3COO)2·2H2O. The structure conformation of ligand 
molecule is done by using various spectroscopic techniques such as 1H NMR, IR and mass. The thermal analyses of 
synthesized metal complexes are carried out by TGA and DTA under inert gas atmosphere. Further, antimicrobial activity of 
these synthesized metal complexes are also checked against some selected bacterial and fungal strains and good to moderate 
biological activity of the metal complexes against selected bacterial and fungal strains are observed in DMF 
and DMSO solvents. 
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In many countries, the treatment of many diseases 
causes by various microorganisms still remains as an 
important and challenging problem as day by day, the 
microorganisms are becoming more and more 
resistive against drug present in the market. Further, 
the numbers of microbial pathogens are also 
increasing which causes serious effect on the health. 
Due to drug resistant microbial pathogens, the new 
compounds have been synthesized by various 
chemists in order to find out new effective leading 
molecules1. Literature shows that the pyrazole 
derivatives possess various biological and 
pharmaceutical activities in medicinal field2-5. 
Pyrazole is the one of the five member heterocyclic 
ring having two adjacent nitrogen atoms. Pyrazole 
derivatives showed biological activities such as 
anticancer6, antimalarial7, antiulcer8, antihypertensive9, 
antiinflammatory10, antidiabetic11, etc. 
Nowadays, the chemistry of metal complexes is 
gaining importance due to their incredible biological 
and pharmaceutical activities12-14. The biological 
activities of pyrazole scaffolds may be further 
enhanced by preparation of metal complexes of such 
pyrazole ligand with various transition metals15,16. 
Among the transition metals, copper, nickel and 
cobalt are most common metals used in synthesis of 
metal complexes17-19. The copper is one of the 
trace elements uses in the formation and activity 
function of many enzymes, proteins, DNA and 
essential for life. The structural modification could 
enhance solubility and stability of heterocyclic 
compounds in the biological medium and enhanced 
biological activities. 
In the present work, the synthesis of some 
transition metal complexes such as Ni(II), Cu(II), 
Co(II), with pyrazole heterocyclic compound as 
ligand molecule was carried out in alcoholic medium. 
The structure conformation of ligand molecule was 
done through 1H NMR, infrared (IR) and mass 
spectral data. Thermal analysis of the synthesized 
metal complexes was done through thermogravimetric 
analysis (TG) and differential thermal analysis (DTA) 
in inert atmosphere. The antimicrobial screening was 
also studied for all synthesized metal complexes 
against selected bacterial and fungal strains in N,N-
dimethyl formamide (DMF) and dimethyl solfoxide 
(DMSO) solvent by agar well diffusion method. 
Materials and Methods 
Chemicals 
The various chemicals used in the synthesis as well 
as in antimicrobial screening were analytical reagent 
grade and purchased from Spectro Chem Pvt. Ltd. and 
used as received. For metal complexes formation, the 
metal salt such as Co(CH3COO)2·6H2O, 
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precipitation, extra solvent was removed by using 
rotary evaporator and the product was filtered, 
washed with cool methanol and dried under vacuum. 
The reaction scheme is shown in Scheme 5.  
 
Results and Discussion 
 
Spectral analysis of ligand 
1H NMR spectrum of OPD-1 is shown in Fig. 1. 
Here it is observed that the proton peak of methyl 
group present in free ligand molecule shows peak in 
up field at δ 2.406 ppm. The proton peak of amino 
group is observed in deshielding region i.e. in down 
field at δ 9.296 ppm due to effect of nitrogen atom. 
The characteristics proton peak of hydroxyl group is 
also observed in deshielding region at δ 8.753 ppm as 
singlet. Other peaks of aromatic protons are observed 
in their appropriate region with appropriate splitting. 
This gives the conformation of synthesis of 
heterocyclic molecules. 
In IR spectrum of OPD-1 as shown in Fig. 2, the 
bands observed at 3385.07, 3311.78 and 3197.98 cm-1 
are due to N-H stretching of amino group present in 
molecule. The N-H stretching of amide group is 
observed in the region of 3310-3335 cm-1. The peaks 
observed in this region are broad which indicates the 
merger of N-H stretching peak with –OH stretching 
peak. The broad band in the region 3300-3400 cm-1; 
shows the presence of free hydroxyl group. The 
characteristics carbonyl stretching peaks are observed 
at 1707 and 1668 cm-1. These absorbance peaks show 
that the presence of two type carbonyl group in the 
molecules. The alkane (-CH-) stretching absorbance 
peaks are observed at 3150-2800 cm-1. In mass 
spectrum of OPD-1 as shown in Fig. 3, the molecular 
ion peak is obtained at 423 m/z.  
 
Spectral analysis of complex 
Fig. 4 shows the IR spectrum of OPD-1 Cu, 
complex. The comparison of IR spectrum of ligand 
molecule with that of metal complex shows that the 
N-H stretching of amide group is observed at 
3385.07, 3311.78 and 3197.98 cm-1 in free ligand 
 
 
Scheme 5 — Scheme for synthesis of metal complexes 




molecule. However, in the IR spectrum of metal 
complex, less intense N-H stretching of amide group 
is observed. The less intensity of stretching peak 
indicates the coordination of the amide group with the 
transition metal. Further, on comparison of IR 
spectrum of pure ligand and metal complex, it is 
observed that the hydroxyl group shows broad peak in 
case free ligand which got disappear in metal 
complex. This indicates that in metal complex, the 
transition metal forms coordinate covalent bond with 
hydroxyl and amide group of ligand molecules. The 
change in the absorption frequency of these groups 
indicates that the metal is attached with oxygen and 
nitrogen atoms of the ligand. 
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Ni (metal complex of nickel with ligand) showed 
lower inhibition as compared OPD-1 Co complex. It 
is clear that against Corynebacterium rubrum in 
DMF, OPD-1 Ni and OPD-1 Co complexes showed 
maximum and almost same extent of inhibition. 
Against Bacillus subtilis, OPD-1 Cu and OPD-1 Ni 
showed same extent of inhibition in DMF. However, 
none of the metal complex showed higher inhibition 
as compared to standard antibiotics. 
From the Fig. 6b, it is observed that the again 
OPD-1 Co showed higher inhibition against Bacillus 
cereus and Corynebacterium rubrum in DMSO. In 
DMSO, all metal complexes also exhibited inhibition 
but low as compared to standard antibiotics. Against 
Bacillus subtilis, OPD-1 Ni showed higher in inhibition 
as compared to rest of two metal complexes,  
OPD-1 Cu and OPD-1 Co. Out of the three 
complexes, OPD-1 Cu, showed minimum inhibition 
against Bacillus cereus and Corynebacterium rubrum 
in DMSO. Hence, it is clear that solvent also plays an 
important role in antibacterial activity. 
 
The zone of inhibition plots of synthesized metal 
complex against some selected gram negative 
bacterial strains in DMF and DMSO are shown in  
Fig. S1 in Supplementary Data. It is observed that all 
the synthesized metal complexes showed good to 
moderate biological activity against Klebsiella 
pneumonia, and Staphylococcus typhimurium. OPD-1 
Co complex showed maximum inhibition whereas 
OPD-1 Ni showed minimum inhibition against all 
three tested bacterial strains in DMF. However, none 
of the metal complex showed inhibition higher than 
that of standard antibiotics used as reference material 
in anti microbial study. In DMSO, once again OPD-1 
Co complex showed higher inhibition against all three 
selected gram negative bacterial strains in compare to 
OPD-1 Cu and OPD-1 Ni complex.  
The antifungal activity of the metal complexes 
against selected fungal strains in DMF and DMSO are 
graphically shown in Fig. S2 (Supplementary Data). 
From this figure, it is observed that all compounds 
showed good to moderate inhibition against selected 
fungal strains in DMF and DMSO solvents. From  
Fig. S2a, it is observed that the OPD-1 Co complex 
showed the maximum and OPD-1 Cu showed the 
minimum inhibition against Candida albicans, 
Candida glabarata and Cryptococcus neoformans in 
DMF. As shown in Fig. S2b, OPD-1 Ni complex 
showed the maximum inhibition against Candida 
albicans and Cryptococcus neoformans in DMSO. 
OPD-1 Cu complex showed the minimum inhibition 
against Candida albicans, Candida glabarata and 
Cryptococcus neoformans in DMSO. However, in 
comparison with reference compounds, all 
synthesized complexes show lower antifungal activity. 
Antimicrobial activities of all the metal complexes were 
carried out by Agar well diffusion method in preparative 
petridishes as shown in Fig. S3 in Supplementary Data.  
 
Conclusions 
In the present study, transition metal complexes 
such as Cu(II), Co(II) and Ni(II) were prepared with 
synthesized (E)-2-hydroxy-5-(3-(1-phenyl-3-(p-tolyl)-
1H-pyrazol-4-yl)acryloyl)benzamide. From thermal 
study of metal complexes, it is observed that degradation 
of these metal complexes is a multi step process and the 
metal complexes are stable up to 300 °C. From the 
degradation pattern and loss of %residue it is 
concluded that in copper metal complex have two 
coordinate water molecules where as in cobalt and 
nickel metal complexes have four coordinate water 
molecules. Further, from the antimicrobial screening; 
it is observed that the metal complexes showed good 
to moderate biological activity against selected 
bacterial and fungal strains in DMF and DMSO. 
 
 
Fig. 6 — Antimicrobial screening of synthesized metal complex
against selected positive bacterial strains in (a) DMF and (b) DMSO 





Supplementary Data associated with this article  





1 Egorov A M, Ulyashova M M & Rubtsova M Y,  
Acta Naturae, 10 (2018) 33. 
2 Karrouchi K, Radi S, Ramli Y, Taoufik J, Mabkhot Y N,  
Al-aizari F A & Mhammed A, Molecules, 23 (2018) 134. 
3 Steinbach G, Lynch P M, Phillips R K S, Wallace M H, 
Hawk E, Gordon G B, Wakabayashi N, Saunders B, Shen Y, 
Fujimura T, Su L K, Levin B, Godio L, Patterson S, 
Rodriguez-Bigas M A, Jester S L, King K L, Schumacher M, 
Abbruzzese J, DuBois R N, Hittelman W N, Zimmerman S, 
Sherman J W & Kelloff G, New Eng J Med Chem,  
342 (2000) 1946. 
4 Uslaner J M, Parmentier-Batteur S, Flick R B, Surles N O, 
Lam J S H, McNaughton C H, Jacobson M A & Hutson P H, 
Neuropharmacology, 57 (2009) 531. 
5 Gosselin F, O’Shea P D, Webster R A, Reamer R A, Tillyer 
R D & Grabowski E J J, Synlett, 19 (2006) 3267. 
6 Ismail M M F, Khalifa N M, Fahmy H H, EL-Sahrawy H M 
& Nossier E S, Biomed Res, 27 (2016) 1087. 
7 Domínguez J N, Charris J E, Caparelli M & Riggione F, 
Arzneim Forsch Drug Res, 52 (2002) 482. 
8 Bhat M A, Al-Omar M A & Naglah A M, J Enzyme Inhib 
Med Chem, 33 (2017) 978. 
9 Trindade N R, Lopes P R, Naves L M, Fajemiroye J O,  
Alves P H, Amaral N O, Lião L M, Rebelo A C S,  
Castro C H, Braga V A, Menegatti R & Pedrino G R, Front 
Physiol, 9 (2018) 10.  
10 Hassan G S, Abdel Rahman D E, Abdelmajeed E A, Refaey 
R H, Alaraby Salem M, & Nissan Y M, Euro J Med Chem, 
171 (2019) 332. 
11 Hassan Feid-Allah R S, El Sadany S K & Mohamed H F,  
J Pharm Sci, 70 (1981) 626. 
12 Gerasimchuk N, Dalton Trans, 48 (2019) 7985. 
13 Lahsasni S A, Ammar R A, Amin M F & Shoukry E, Int J 
Electrochem Sci, 7 (2012) 7699. 
14 Sigel H, Operschall B P, Massoud S S, Song B & Griesser R, 
Dalton Trans, 46 (2006) 5521. 
15 Singh K, Thakur R & Kumar V, Beni-Suef University J Basic 
Appl Sci, 5 (2016) 21. 
16 Czarnomysy R, Surażyński A, Muszynska A, Gornowicz A, 
Bielawska A & Bielawski K, J Enzyme Inhib Med Chem,  
33 (2018) 1006. 
17 Singh J & Singh P, Inter Scholarly Res Notices, 2012 (2012) 
Article ID 504038. 
18 Tordin E, List M, Monkowius U, Schindler S, & Knör G, 
Inorg Chim Acta, 402 (2013) 90. 
19 Papish E T, Taylor M T, Jernigan F E, Rodig M J,  
Shawhan R R, Yap G P A, & Jové F A, Inorg Chem, 45 
(2006) 2242. 
  
 
